Ahmedabad, India - July 16, 2024: Epigral Limited (formerly known as Meghmani Finechem Limited), a prominent name in the chemicals industry, has announced a forthcoming Board Meeting scheduled for Wednesday, July 24, 2024. The meeting will take place at the company's headquarters, Epigral Tower, located behind Safal Profitaire on Corporate Road in Prahladnagar, Ahmedabad.
The Board of Directors will convene to consider and approve the Un-audited Financial Results for the first quarter ended June 30, 2024. This meeting will also include the review of the Limited Review Report from the company's statutory auditors.
Key Agenda:
This announcement is in accordance with Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring that shareholders and members are adequately informed.
Gaurang Trivedi, Company Secretary & Compliance Officer, expressed confidence in the company's ongoing strategic initiatives and financial health. This meeting is a crucial step in maintaining transparency and keeping stakeholders informed about the company's financial performance.
Shareholders and interested parties are encouraged to stay tuned for the outcome of the meeting and the subsequent financial disclosures.
About Epigral Limited: Epigral Limited, formerly known as Meghmani Finechem Limited, continues to be a key player in the chemicals sector, focusing on delivering high-quality products and maintaining robust financial practices. The company's commitment to excellence and innovation has positioned it as a trusted name in the industry.
For further information, please contact:
Leave a comment